Oxiconazole dosage and administration

Revision as of 08:13, 9 January 2014 by Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Oxiconazole}} {{CMG}}; {{AE}} {{AZ}} ==Dosage and Administration== OXISTAT® Cream or Lotion should be applied to affected and '''immediately''' surrounding area...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Oxiconazole
OXISTAT® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Dosage and Administration

OXISTAT® Cream or Lotion should be applied to affected and immediately surrounding areas once to twice daily in patients with tinea pedis, tinea corporis, ortinea cruris. OXISTAT® Cream should be applied once daily in the treatment of tinea versicolor (pityriasis).

Tinea corporis, tinea cruris, and tinea (pityriasis) versicolor should be treated for 2 weeks and tinea pedis for 1 month to reduce the possibility of recurrence.

If a patient shows no clinical improvement after the treatment period, the diagnosis should be reviewed.

Note: Tinea (pityriasis) versicolor may give rise to hyperpigmented or hypopigmented patches on the trunk that may extend to the neck, arms, and upper thighs. Treatment of the infection may not immediately result in restoration of pigment to the affected sites. Normalization of pigment following successful therapy is variable and may take months, depending on individual skin type and incidental sun exposure.

Although tinea (pityriasis) versicolor is not contagious, it may recur because the organism that causes the disease is part of the normal skin flora.[1]

References

  1. "OXISTAT (OXICONAZOLE NITRATE) CREAM OXISTAT (OXICONAZOLE NITRATE) LOTION [PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC.]".

Adapted from the FDA Package Insert.